Viridian Therapeutics, Inc. VRDN Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s common stock?
- Viridian Therapeutics, Inc. (VRDN) reported common stock of 200M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s common stock changed year-over-year?
- Viridian Therapeutics, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s common stock?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s common stock has grown at a 443.9% compound annual growth rate (CAGR), from 42K to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).